tradingkey.logo
tradingkey.logo
Buscar

National Research Corp

NRC
Añadir a la lista de seguimiento
22.400USD
+0.060+0.27%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
507.07MCap. mercado
55.95P/E TTM

Más Datos de National Research Corp Compañía

National Research Corporation, doing business as NRC Health, is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare organizations in the United States. Its digital solutions consist of four solution categories: Patient Experience, Consumer Experience, Employee Experience, and Market Experience, which can be implemented both collectively as an enterprise solution or individually to meet specific needs within the organization. Its Marketing solutions are subscription-based services that allow for improved tracking of awareness, perception, and consistency of healthcare brands; real-time assessment of competitive differentiators, and enhanced segmentation tools. Its Reputation solutions allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs better consumer decision-making.

Información de National Research Corp

Símbolo de cotizaciónNRC
Nombre de la empresaNational Research Corp
Fecha de salida a bolsaOct 01, 1997
Director ejecutivoGreen (Trent S)
Número de empleados368
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 01
Dirección1245 Q Street
CiudadLINCOLN
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal68508
Teléfono14024752525
Sitio Webhttps://nrchealth.com/
Símbolo de cotizaciónNRC
Fecha de salida a bolsaOct 01, 1997
Director ejecutivoGreen (Trent S)

Ejecutivos de National Research Corp

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Andrew (Andy) Monnich
Mr. Andrew (Andy) Monnich
Chief Corporate Development Officer
Chief Corporate Development Officer
100.00K
--
Mr. Michael D. Hays
Mr. Michael D. Hays
Chairman of the Board
Chairman of the Board
96.25K
--
Mr. John N. Nunnelly
Mr. John N. Nunnelly
Lead Independent Director
Lead Independent Director
40.36K
+19.07%
Ms. Parul Bhandari
Ms. Parul Bhandari
Independent Director
Independent Director
7.70K
--
Dr. Stephen H. Lockhart, M.D., Ph.D.
Dr. Stephen H. Lockhart, M.D., Ph.D.
Independent Director
Independent Director
7.70K
--
Dr. Penny A. Wheeler
Dr. Penny A. Wheeler
Independent Director
Independent Director
--
--
Ms. Helen L. Hrdy
Ms. Helen L. Hrdy
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Trent Green
Mr. Trent Green
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Shane Harrison
Mr. Shane Harrison
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Dr. Donald M. Berwick
Dr. Donald M. Berwick
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Andrew (Andy) Monnich
Mr. Andrew (Andy) Monnich
Chief Corporate Development Officer
Chief Corporate Development Officer
100.00K
--
Mr. Michael D. Hays
Mr. Michael D. Hays
Chairman of the Board
Chairman of the Board
96.25K
--
Mr. John N. Nunnelly
Mr. John N. Nunnelly
Lead Independent Director
Lead Independent Director
40.36K
+19.07%
Ms. Parul Bhandari
Ms. Parul Bhandari
Independent Director
Independent Director
7.70K
--
Dr. Stephen H. Lockhart, M.D., Ph.D.
Dr. Stephen H. Lockhart, M.D., Ph.D.
Independent Director
Independent Director
7.70K
--
Dr. Penny A. Wheeler
Dr. Penny A. Wheeler
Independent Director
Independent Director
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de National Research Corp?

Los cinco principales accionistas de National Research Corp son: Mr. Andrew (Andy) Monnich

¿Cuántas instituciones poseen acciones de National Research Corp (NRC)?

A fecha de 2026Q1, 322 instituciones poseen acciones de National Research Corp, con un valor de mercado combinado de aproximadamente 12.06M, lo que representa el 53.51% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -824455.00.